Increased circulating levels of eotaxin have been described in fibromyalgia [101, 102] and in several neuroinflammatory disorders [103] such as Alzheimer’s disease [104, 105], amyotrophic lateral sclerosis, Huntington’s disease, and secondary progressive multiple sclerosis [105]. Here, CCL11 is linked to early-onset autosomal dominant Alzheimer disease.